EX-23.1 15 d145328dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Amendment to the Registration Statement No. 333-257604 on Form S-1 of our report dated May 7, 2021 (July 19, 2021 as to the effects of the stock split described in Note 2 and Note 15), relating to the financial statements of Caribou Biosciences, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

San Francisco, California

July 19, 2021